Biotechnology Stocks II Performance Guide: BioCryst Pharmaceuticals, Inc. (BCRX)
BCRX has no dividends.
Table and Chart of BCRX Performance
See what a $1,000 investment in BCRX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| BCRX Returns | |
|---|---|
| Start Date | Jul-31-2014 |
| Start Price | $12.52 |
| End Date | Jul-26-2024 |
| End Price | $7.85 |
| # Prices | 121 |
| Min Date | Feb-29-2016 |
| Min Price | $1.99 |
| Max Date | Feb-28-2022 |
| Max Price | $16.61 |
| Total Return | -37.30% |
| Annualized Return | -4.52% |
| Current Value of $1,000 Purchase | $627 |
| Number Returns | 7,260 |
| Average Return | 39.81% |
| Number Profitable Returns | 3,738 |
| Percent Profitable Returns | 51.49% |
| Number Unprofitable Returns | 3,522 |
| Percent Unprofitable Returns | 48.51% |
| Profitable to Unprofitable Returns Ratio | 1.06 |
| BCRX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,580,621,000 |
| Beta | 1.879 | Price to Sales | 2.97 |
| Earnings per Share | $-1.0700 |
| PE Ratio | None |
| PE to Growth Ratio | -0.28 |
| Price to Book | 56.59 |
| PRICE DATA | |
| 52 Week High | $7.87 |
| 52 Week Low | $4.03 |
| Analyst Target Price | $14 |
| 50-Day Moving Average | $6.55 |
| 200-Day Moving Average | $5.75 |
| FINANCIAL DATA | |
| Revenue per Share | $1.808 |
| Revenue | $355,395,000 |
| Profit Margin | -58.7% |
| Return on Equity | -1925% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
BCRX Compare Returns with S&P 500
BCRX Trendline Chart
BCRX Moving Average Chart
BCRX Stock Return Map - See Patterns of Gains and Losses
BCRX Stock Returns/Purchase Dates